Depression in glioma: a primer for clinicians and researchers.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24029545.
- Also identified by DOI 10.1136/jnnp-2013-306497.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Depression is one of the leading causes of global disability, and a considerable hidden morbidity among patients with glioma. In this narrative review, we summarise what is currently known about depression in glioma, the main unanswered questions and the types of studies that should be prioritised in order to find out. We conclude by calling for a prospective Phase II study of antidepressants in depressed glioma patients, to test methodologies for a multicentre randomised controlled trial.
Medical subject headings
- Antidepressive Agents
- Depression
- Glioma